Genenta Science S.p.A. Marketable Securities, Unrealized Gain (Loss)
Genenta Science S.p.A. (GNTA) reported Marketable Securities, Unrealized Gain (Loss) of EUR 100.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-04-01
| Period end | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|
| 2025-12-31 | 100.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 70.17K EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 96.00K EUR 20-F · filed 2025-03-28 | |
| 2024-06-30 | 100.00K EUR 6-K · filed 2024-10-29 | |
| 2023-12-31 | 268.00K EUR 20-F · filed 2024-03-29 |